| Primary information |
|---|
| sequence ID | Seq_3916 |
| Peptide sequence | ISRAQLVPLPPSTY |
| CancerPDF_ID | CancerPDF_ID143, CancerPDF_ID10187, |
| PMID | 17269714,21805675 |
| Protein Name | Alpha-2-HS-glycoprotein,Alpha-2-HS-glycoprotein |
| UniprotKB Entry Name | FETUA_HUMAN,FETUA_HUMAN |
| Fluid | Plasma,Urine |
| M/Z | NA,1541.8717 |
| Charge | 1,NA |
| Mass (in Da) | 1541.88,NA |
| fdr | NA,NA |
| Profiling Technique | MALDI-TOF,MALDI-TOF |
| Peptide Identification technique | LC-MS/MS,MALDI-TOF-MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,1 |
| CancerPDF_ID | CancerPDF_ID143, CancerPDF_ID10187, |
| p-Value | NA,NA |
| Software | MASCOT (v 2.1.0),NA |
| Length | 14,14 |
| Cancer Type | Normal,Muscle-invasive bladder cancer |
| Database | MSDB Human Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | NA,751 bladder cancer and 127 control |
| Regulation | NA,Differentially expressed between cancer vs normal samples |
| Validation | NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |